Skip to main content
. 2015 Aug 19;6(31):31604–31612. doi: 10.18632/oncotarget.5231

Table 2. Comparisons table and log-rank test for prognostic factor categories.

POPULATION
[K-Ras mutated codons]
PFS (95%CI)
[mts]
OS (95%CI)
[mts]
Codon 12,
all patients (pts)
8.25 (95%CI: 7.48-9.01) 28 (95%CI: 23.67-32.32)
Codon 12,
pts with >40% vs ≤40% mutant alleles
7.45 (95%CI: 5.78-9.21) vs 9.45 (95%CI: 8.47-10.4) 23 (95%CI: 19.79-26.20) vs 31 (95%CI: 27.00-34.99)
Codon 13,
all pts
8.90 (95%CI: 7.69-10.10) 21 (95%CI: 16.63-25.36)
Codon 13,
pts with >40% vs ≤40% mutant alleles
7.25 (95%CI: 3.6-10.89) vs 10.25 (95%CI: 8.15-12.32) 17 (95%CI: 11.61- 22.78) vs 24 (95%CI: 19.41- 28.58)
Rare codons,
all pts
5.50 (95%CI: 2.95- 8.04) 31 (95%CI: 27.03-34.03)
Rare codons,
pts with >40% vs ≤40% mutant alleles
5.5 (95%CI: 10.75-31.04) vs 7.25 (95%CI: 2.44-12.05) -
All K- Ras mutated codons,
pts with >40% vs ≤40% mutant alleles
7.25 (95%CI: 5.76-8.73) vs 9 (95%CI: 7.96-10.03) 21 (95%CI: 18.35-23.64) vs 31 (95%CI: 26.66-35.33)
Log-Rank P P=0.000 P=0.002